Endotherapy Devices Market Size, Share, Growth, and Industry Analysis, By Type (GI Devices & Accessories, ERCP Devices & Accessories, Others), By Application (Hospitals, Clinics, Others), Regional Insights and Forecast to 2035

Endotherapy Devices Market Overview

The global Endotherapy Devices Market size estimated at USD 8663.45 million in 2026 and is projected to reach USD 12840.33 million by 2035, growing at a CAGR of 4.47% from 2026 to 2035.

The Endotherapy Devices Market is expanding as gastrointestinal endoscopy becomes central to minimally invasive diagnosis and treatment. More than 20 million gastrointestinal endoscopic procedures are performed annually in the United States, while colorectal cancer remains among the most frequently diagnosed cancers worldwide. GI devices and accessories account for approximately 56% of endotherapy device demand, while ERCP devices and accessories represent about 31%, and other products hold nearly 13%. Hospitals generate approximately 68% of product utilization. Single-use accessories, advanced hemostasis tools, guidewires, retrieval devices, dilation systems, injection needles, and polypectomy products are strengthening the Endotherapy Devices Market Outlook and supporting broader therapeutic endoscopy adoption.

The United States represents approximately 33% of global Endotherapy Devices Market demand, supported by more than 6,000 hospitals and an extensive outpatient endoscopy network. Around 15 million colonoscopies are performed annually across the country, creating substantial consumption of biopsy forceps, snares, clips, guidewires, injection needles, retrieval devices, and dilation accessories. Hospitals account for approximately 66% of U.S. endotherapy device utilization, while clinics and ambulatory facilities represent about 27%. Colorectal cancer screening remains a major demand source because adults aged 45 to 75 are targeted for routine screening. Disposable accessories represent more than 55% of procedure-related accessory usage.

Key Findings

• Key Market Driver: Minimally invasive gastrointestinal procedures generate approximately 72% of therapeutic endoscopy demand, while screening-related interventions contribute nearly 28%, strengthening recurring consumption of endotherapy accessories across hospitals and outpatient centers.
• Major Market Restraint: Approximately 46% of smaller healthcare facilities face purchasing pressure from advanced device costs, while nearly 31% report limitations associated with specialized training, reprocessing requirements, and procedure infrastructure.
• Emerging Trends: Single-use and infection-control-oriented accessories account for approximately 58% of purchasing preference in high-volume settings, while advanced therapeutic and precision-designed devices represent nearly 42% of emerging product adoption.
• Regional Leadership: North America accounts for approximately 38% of Endotherapy Devices Market Share, followed by Europe at 29%, Asia-Pacific at 26%, and Middle East & Africa at approximately 7%.
• Competitive Landscape: Leading multinational manufacturers collectively control approximately 64% of organized market supply, while regional and specialized manufacturers represent approximately 36%, creating competition across therapeutic accessories, ERCP products, and disposable devices.
• Market Segmentation: GI devices and accessories represent approximately 56% of product demand, ERCP devices and accessories hold about 31%, and other specialized endotherapy products account for the remaining 13% share.
• Recent Development: Approximately 61% of major manufacturers are increasing focus on single-use and improved infection-control products, while 39% are prioritizing enhanced therapeutic performance, ergonomics, navigation, and precision intervention technologies.

Endotherapy Devices Market Latest Trends

Endotherapy Devices Market Trends increasingly center on minimally invasive treatment, disposable accessories, improved hemostasis, and precision tissue removal. Approximately 58% of accessory purchasing in high-volume endoscopy settings is moving toward single-use solutions where infection prevention and workflow efficiency are major considerations. Therapeutic procedures account for an increasing proportion of endoscopic workloads as clinicians use clips, snares, injection needles, guidewires, dilation devices, and retrieval products during the same diagnostic session.

Digital endoscopy and advanced imaging are also influencing Endotherapy Devices Market Growth. Approximately 67% of large endoscopy centers prioritize products compatible with advanced visualization platforms, while nearly 54% emphasize improved device maneuverability. Around 49% of procurement decisions increasingly consider reduced procedure time and simplified preparation.

Endotherapy Devices Market Dynamics

DRIVER

"Growing adoption of minimally invasive gastrointestinal procedures"

The strongest driver of Endotherapy Devices Market Growth is the expanding use of minimally invasive gastrointestinal diagnosis and treatment. More than 15 million colonoscopies are performed annually in the United States alone, while upper gastrointestinal endoscopy, ERCP, endoscopic ultrasound, polypectomy, dilation, hemostasis, and foreign-body removal create additional device consumption. Approximately 72% of therapeutic endoscopy demand is associated with procedures designed to diagnose and treat gastrointestinal abnormalities without open surgery. Colorectal cancer screening recommendations covering adults from age 45 have widened the eligible screening population. Hospitals perform approximately 68% of endotherapy procedures requiring specialized accessories, supporting recurring purchasing of snares, forceps, clips, guidewires, injection needles, baskets, balloons, and dilation systems. These procedure volumes make minimally invasive treatment a central factor in Endotherapy Devices Market Analysis and long-term procurement planning.

RESTRAINTS

"High equipment costs and complex reprocessing requirements"

Cost pressure and complex device management restrain Endotherapy Devices Market expansion, particularly in smaller clinics and healthcare systems with limited procedure volumes. Approximately 46% of smaller facilities face purchasing limitations when adopting advanced therapeutic accessories and supporting endoscopy infrastructure. Around 31% identify staff training, cleaning, sterilization, storage, and reprocessing requirements as important operational barriers. Reusable products can require multiple cleaning and disinfection stages, while single-use alternatives increase recurring procurement expenditure. Facilities must also maintain skilled gastroenterologists, trained nurses, technicians, sterilization personnel, and procedure-room infrastructure. In lower-resource healthcare systems, specialist shortages further restrict procedure availability. 

OPPORTUNITY

"Expansion of single-use therapeutic accessories and outpatient endoscopy"

Single-use products and outpatient gastrointestinal procedures create major Endotherapy Devices Market Opportunities. Approximately 58% of purchasing preference in high-throughput settings is shifting toward disposable accessories where contamination control, predictable performance, and faster room turnover are prioritized. Ambulatory surgical centers and specialty clinics account for approximately 24% of application demand and are gaining importance as selected colonoscopy, biopsy, polypectomy, dilation, and other endoscopic procedures move outside traditional inpatient settings. Manufacturers can target this shift with ready-to-use snares, biopsy forceps, injection needles, retrieval baskets, guidewires, clips, balloons, and other accessories. 

CHALLENGE

"Specialist shortages and stringent device performance requirements"

A major Endotherapy Devices Market challenge is maintaining consistent device performance while expanding access to skilled therapeutic endoscopy. Advanced ERCP, complex polypectomy, endoscopic hemostasis, stricture management, and biliary interventions require experienced physicians and trained support teams. Approximately 39% of adoption barriers in developing healthcare environments are connected with limited specialist availability and uneven access to advanced endoscopy centers. At the same time, manufacturers must meet strict requirements for biocompatibility, mechanical reliability, sterility, traceability, packaging integrity, and procedural safety. Products such as guidewires, clips, sphincterotomes, dilation balloons, retrieval baskets, and snares must function precisely within narrow anatomical spaces. Approximately 44% of institutional procurement evaluations emphasize reliability and procedural compatibility as major selection factors. 

Endotherapy Devices Market Segmentation

Endotherapy Devices Market segmentation is primarily evaluated by type and application. By type, GI devices and accessories account for approximately 56% of demand, ERCP devices and accessories represent around 31%, and other products hold approximately 13%. By application, hospitals dominate with approximately 68% share because they perform high volumes of diagnostic and therapeutic gastrointestinal procedures. Clinics account for nearly 24%, while other healthcare settings represent approximately 8%. This segmentation supports Endotherapy Devices Market Research Report assessments of purchasing patterns, procedure volumes, product utilization, and end-user requirements.

BY TYPE

GI Devices & Accessories: GI devices and accessories hold approximately 56% of Endotherapy Devices Market Share, making this the largest product category. The segment includes biopsy forceps, polypectomy snares, hemostasis clips, injection needles, dilation balloons, retrieval devices, cytology brushes, graspers, cleaning accessories, and other instruments used during gastrointestinal endoscopy. Colonoscopy represents one of the largest procedure bases, with approximately 15 million examinations performed annually in the United States. Screening, tissue sampling, polyp removal, gastrointestinal bleeding management, stricture treatment, and foreign-body extraction generate recurring accessory consumption. Around 62% of high-volume gastrointestinal centers use multiple therapeutic accessories during complex procedures, increasing unit demand per intervention. 

ERCP Devices & Accessories: ERCP devices and accessories account for approximately 31% of the Endotherapy Devices Market. This segment includes guidewires, sphincterotomes, extraction balloons, stone retrieval baskets, biliary dilation balloons, cannulas, cytology devices, drainage accessories, and products supporting pancreatic and biliary interventions. ERCP is primarily therapeutic and is widely used for bile duct stones, biliary obstruction, strictures, leaks, and selected pancreatic conditions. Approximately 71% of ERCP-related accessory demand comes from hospitals because procedures require fluoroscopy, specialized endoscopy equipment, sedation capabilities, and experienced clinical teams. Guidewires and extraction devices generate high repeat usage because multiple accessories can be required within a single intervention. 

Others: Other endotherapy products account for approximately 13% of overall market demand and cover specialized devices used in less common or highly complex therapeutic procedures. The category can include specialized stent accessories, advanced retrieval tools, selected endoscopic suturing components, drainage-related devices, treatment probes, and procedure-specific accessories that fall outside broad GI and ERCP product groups. Approximately 57% of demand in this segment comes from tertiary hospitals and advanced gastrointestinal treatment centers because these institutions manage complex referrals and difficult cases. Around 43% is distributed among specialty clinics, academic facilities, and other care environments. Product innovation has an important influence on this category, as manufacturers develop tools designed for improved tissue access, controlled deployment, better maneuverability, and reduced procedure complexity. 

BY APPLICATION

Hospitals: Hospitals account for approximately 68% of Endotherapy Devices Market application demand, making them the largest end-user category. Their leadership reflects high procedure volumes, emergency gastrointestinal treatment capabilities, advanced imaging systems, specialist availability, and infrastructure for complex interventions. Approximately 74% of advanced ERCP procedures are conducted in hospital-based or closely affiliated specialist environments because biliary and pancreatic interventions may require anesthesia, fluoroscopy, recovery monitoring, and multidisciplinary support. Hospitals consume large quantities of snares, biopsy forceps, guidewires, injection needles, clips, dilation balloons, retrieval baskets, sphincterotomes, and other accessories. 

Clinics: Clinics represent approximately 24% of Endotherapy Devices Market demand and are gaining importance as gastrointestinal screening and selected therapeutic procedures shift toward outpatient environments. Specialty gastroenterology clinics and ambulatory endoscopy centers commonly perform colonoscopy, upper GI endoscopy, biopsy, polypectomy, injection therapy, and selected dilation procedures. Approximately 61% of clinic-based purchasing decisions prioritize products that can simplify workflow, reduce preparation requirements, and support rapid patient turnover. Single-use accessories are particularly suitable for outpatient settings because they can reduce dependence on complex reprocessing workflows for selected instruments. Around 56% of clinic demand is associated with routine diagnostic and low-to-moderate complexity therapeutic procedures. 

Others: Other applications hold approximately 8% of Endotherapy Devices Market Share and include academic medical centers, specialized diagnostic centers, research institutions, and selected day-care surgical facilities not classified within conventional hospital or clinic channels. Approximately 52% of demand within this category comes from specialist and academic environments where advanced procedures, physician training, clinical evaluation, and device testing are concentrated. The remaining 48% is associated with diagnostic and alternative outpatient facilities. These end users often require smaller purchasing volumes but can influence adoption of new technologies because specialist physicians evaluate advanced therapeutic tools before broader commercial use. 

Endotherapy Devices Market Regional Outlook

The Endotherapy Devices Market shows strong regional variation based on gastrointestinal procedure volumes, screening coverage, hospital infrastructure, specialist availability, and access to advanced endoscopy systems. North America accounts for approximately 38% of global market demand, followed by Europe with 29%, Asia-Pacific with 26%, and Middle East & Africa with 7%, representing an overall 100% share. North America benefits from established screening programs and advanced hospitals, while Europe has broad endoscopic care networks. Asia-Pacific is increasing procedure capacity through hospital expansion and larger patient populations, while Middle East & Africa is developing specialized gastrointestinal treatment infrastructure.

NORTH AMERICA

North America holds approximately 38% of the Endotherapy Devices Market Share, supported by extensive gastrointestinal screening, high endoscopy procedure volumes, and broad adoption of minimally invasive treatment. The United States represents the majority of regional demand, with more than 15 million colonoscopies performed annually. Hospitals and hospital-associated endoscopy units account for approximately 66% of regional device utilization.

Single-use biopsy forceps, snares, injection needles, guidewires, clips, retrieval devices, and ERCP accessories are widely utilized across the region. Approximately 62% of large endoscopy facilities emphasize disposable accessories for selected procedures, while nearly 54% prioritize devices that improve procedure efficiency. An aging population and colorectal cancer screening among adults aged 45 to 75 support recurring demand and strengthen the North American Endotherapy Devices Market Outlook.

EUROPE

Europe accounts for approximately 29% of global Endotherapy Devices Market demand. Germany, France, Italy, Spain, and the United Kingdom represent major procedure centers because of established gastroenterology departments and colorectal cancer screening programs. Hospitals account for approximately 69% of regional demand, while clinics, outpatient centers, and other healthcare facilities collectively contribute approximately 31% of product consumption.

Approximately 57% of large European endoscopy facilities place strong procurement emphasis on infection prevention and standardized reprocessing practices. Demand is concentrated across biopsy accessories, polypectomy snares, hemostasis clips, dilation systems, guidewires, and ERCP devices. Around 52% of advanced procurement decisions also emphasize reduced procedure complexity and better maneuverability. These characteristics support Europe within Endotherapy Devices Market Analysis and Endotherapy Devices Industry Analysis.

ASIA-PACIFIC

Asia-Pacific represents approximately 26% of the Endotherapy Devices Market, supported by large patient populations and expansion of hospital-based endoscopy services. China, Japan, India, South Korea, and Australia represent important demand centers. Hospitals generate approximately 72% of regional endotherapy device consumption, reflecting the concentration of advanced gastrointestinal interventions and ERCP procedures within large medical institutions and specialist centers.

Approximately 63% of major urban endoscopy facilities in the region are increasing adoption of advanced therapeutic accessories, while nearly 49% are emphasizing disposable products for selected procedures. Expanding colorectal screening, growing awareness of gastrointestinal disorders, and increasing availability of trained specialists are strengthening demand. Asia-Pacific therefore represents a major area for Endotherapy Devices Market Opportunities, particularly for scalable accessory portfolios and cost-efficient therapeutic products.

MIDDLE EAST & AFRICA

Middle East & Africa accounts for approximately 7% of global Endotherapy Devices Market demand. Gulf countries, South Africa, and selected developing healthcare markets account for a substantial portion of regional utilization. Hospitals represent approximately 78% of device demand because advanced gastrointestinal diagnosis, ERCP, endoscopic hemostasis, and complex therapeutic procedures remain concentrated in large public and private medical centers.

Approximately 46% of leading urban hospitals are expanding advanced gastrointestinal procedure capabilities, while nearly 39% are increasing procurement of disposable endoscopy accessories. Specialist availability and uneven healthcare infrastructure continue to limit broader penetration. However, hospital modernization, medical tourism, specialist training, and development of tertiary treatment centers are improving the Endotherapy Devices Market Outlook and supporting demand for GI and ERCP accessories.

List of top Endotherapy Devices Market Companies

• Olympus
• Stryker
• Boston Scientific
• Fujifilm
• Conmed
• Medtronic
• Karl Storz
• Johnson & Johnson
• Smith & Nephew
• Hoya

Top Two Companies with Highest Market Share

• Olympus: Holds approximately 24% share, supported by extensive gastrointestinal endoscopy systems, therapeutic accessories, established hospital relationships, and broad international distribution.
• Boston Scientific: Holds approximately 18% share, supported by strong ERCP, biliary, hemostasis, polypectomy, dilation, guidewire, and therapeutic gastrointestinal device portfolios.

Investment Analysis and Opportunities

Investment activity in the Endotherapy Devices Market is increasingly directed toward disposable accessories, advanced therapeutic systems, manufacturing automation, and gastrointestinal procedure technologies. Approximately 58% of strategic product investment is focused on single-use or infection-control-oriented devices, reflecting hospital demand for standardized product performance and reduced cross-contamination risks. Around 47% of manufacturers are allocating greater development resources toward therapeutic accessories designed to simplify complex procedures, while approximately 42% are strengthening manufacturing capacity and supply-chain resilience. 

Investment opportunities are also developing around outpatient endoscopy, ERCP accessories, hemostasis products, polypectomy tools, and precision retrieval systems. Approximately 54% of institutional buyers consider procedural efficiency a major purchasing factor, while nearly 49% prioritize compatibility with existing endoscopy systems. Around 44% of healthcare procurement teams are increasing attention to products that can reduce preparation, handling, or reprocessing requirements. Manufacturers targeting clinics can benefit from approximately 24% application share represented by outpatient and specialty facilities. Strategic partnerships with hospitals, distributors, training centers, and gastroenterology specialists can improve product adoption. These conditions strengthen Endotherapy Devices Market Forecast opportunities for suppliers offering broad portfolios, dependable supply, specialist training, and differentiated disposable technologies.

New Products Development

New product development in the Endotherapy Devices Market is centered on improved maneuverability, controlled deployment, stronger hemostasis, simplified cannulation, and single-use designs. Approximately 61% of major product development programs emphasize disposable or infection-control-focused accessories, while nearly 52% target improved procedural precision. Manufacturers are refining guidewire coatings, snare configurations, clip deployment systems, balloon materials, catheter flexibility, and retrieval mechanisms. Around 48% of product development initiatives focus on reducing procedural complexity, while approximately 43% prioritize improved ergonomics for physicians and endoscopy teams. 

ERCP innovation is another major component of Endotherapy Devices Industry Analysis. Approximately 46% of specialized development activity focuses on biliary access, stone extraction, stricture management, drainage, or related therapeutic applications. Around 41% of manufacturers are increasing compatibility between accessories and modern visualization platforms, while nearly 39% are improving packaging and ready-to-use product configurations. Product portfolios increasingly include specialized snares, forceps, guidewires, dilation balloons, retrieval baskets, sphincterotomes, injection needles, and clipping systems designed for specific clinical situations. Approximately 55% of high-volume centers prefer accessories that combine predictable deployment with simplified setup. These priorities are shaping Endotherapy Devices Market Trends and creating competitive opportunities for manufacturers that can improve clinical performance without adding unnecessary workflow complexity.

Five Recent Developments

• Olympus product development activity continued to emphasize therapeutic endoscopy and improved gastrointestinal workflow, with approximately 60% of portfolio-oriented innovation focused on minimally invasive and procedure-support technologies. The strategy emphasizes improved visualization compatibility, therapeutic access, and streamlined clinical workflows for high-volume endoscopy departments.
• Boston Scientific the company continued strengthening gastrointestinal and biliary intervention technologies, with approximately 55% of relevant portfolio emphasis associated with minimally invasive therapeutic procedures. Development priorities included improved access, tissue management, hemostasis, drainage, and procedure-specific accessories supporting advanced endoscopy environments.
• Fujifilm endoscopy portfolio development increased focus on advanced visualization and therapeutic integration, with approximately 52% of associated innovation attention directed toward improving diagnostic-to-treatment workflows. Enhanced imaging compatibility supports more precise identification of gastrointestinal abnormalities and subsequent therapeutic device utilization during procedures.
• Medtronic gastrointestinal technology development increasingly incorporated intelligent detection and procedure-support capabilities, with approximately 48% of related innovation activity emphasizing improved identification and intervention workflows. These developments support earlier lesion recognition and create stronger integration between diagnostic endoscopy and therapeutic treatment pathways.
• Conmed development activities in minimally invasive procedural products emphasized efficiency, disposable technologies, and improved clinical handling, with approximately 45% of relevant portfolio activity targeting workflow-oriented improvements. Product optimization focused on predictable performance and practical use across hospital and ambulatory procedure environments.

Report Coverage Of Endotherapy Devices Market

The Endotherapy Devices Market Report evaluates product demand across GI devices and accessories, ERCP devices and accessories, and other therapeutic endoscopy products. GI devices account for approximately 56% of product demand, ERCP devices represent approximately 31%, and other devices hold nearly 13%. Application analysis covers hospitals with approximately 68% share, clinics with nearly 24%, and other end users with approximately 8%. The Endotherapy Devices Market Research Report also examines biopsy forceps, snares, clips, guidewires, injection needles, dilation balloons, retrieval baskets, sphincterotomes, and other procedure-specific accessories.

Regional coverage represents 100% of assessed market demand, including North America at approximately 38%, Europe at 29%, Asia-Pacific at 26%, and Middle East & Africa at 7%. The Endotherapy Devices Industry Report evaluates competitive positioning, product innovation, procurement behavior, minimally invasive procedure adoption, outpatient endoscopy, infection-control requirements, and specialist availability. The Endotherapy Devices Market Analysis also assesses Market Size indicators, Market Share patterns, Market Growth factors, Market Trends, Market Forecast considerations, Market Outlook, Market Insights, and Market Opportunities relevant to manufacturers, distributors, hospitals, clinics, investors, procurement teams, and other B2B stakeholders.